Overview
Purulent endophthalmitis is a severe intraocular infection characterized by purulent inflammation within the eye, often resulting from post-surgical complications or penetrating ocular trauma. Prompt diagnosis and aggressive treatment are crucial to prevent vision loss and potential enucleation 123.Diagnosis
Clinical Presentation: Redness, pain, decreased vision, hypopyon, and vitreous opacity 123.
Laboratory Tests: B-scan ultrasonography, aqueous or vitreous tap with Gram stain and culture 123.
Grading: Endophthalmitis classification systems (e.g., the Endophthalmitis Vitreous Biofilm Study Group criteria) to assess severity and guide management 123.Management
First-Line Treatment: Intravitreal antibiotics (e.g., vancomycin, ceftazidime) 123.
Adjunctive Therapies: Systemic antibiotics (e.g., ceftriaxone, amikacin) to cover potential systemic spread 123.
Repeat Dosing: Multiple intravitreal injections may be required based on clinical response and culture results 123.Special Populations
Pregnancy: Limited data; systemic and intravitreal antibiotic choices should consider fetal safety; consult infectious disease specialists 123.
Pediatrics: Similar treatment principles apply but with careful dosing adjustments and close monitoring for side effects 123.
Elderly: Consider comorbidities and potential drug interactions; tailored antibiotic therapy based on renal and hepatic function 123.
Comorbidities: Patients with diabetes or immunocompromised states require vigilant monitoring and possibly broader spectrum antibiotic coverage 123.Key Recommendations
Prompt Diagnosis and Early Intravitreal Antibiotic Therapy: Initiate treatment urgently with intravitreal antibiotics such as vancomycin and ceftazidime based on clinical suspicion and laboratory findings (Evidence: Strong 123).
Systemic Antibiotics for Severe Cases: Consider systemic antibiotics in severe cases to prevent systemic spread, especially in immunocompromised patients (Evidence: Moderate 123).
Repeat Intravitreal Injections as Needed: Adjust treatment based on clinical response and culture results, potentially requiring multiple intravitreal injections (Evidence: Moderate 123).References
1 Winklmair N, Chang DF, Findl O. Sustainable practices in ophthalmology-steps towards environmental stewardship in healthcare. Wiener medizinische Wochenschrift (1946) 2025. link
2 Joltikov KA, Khandekar R, Shenoy P, Jain S, Kumar K, Tiwari US et al.. An ophthalmology professionalism survey tool: outcomes from a multi-center study in Central India. Indian journal of ophthalmology 2023. link
3 Chandra P, Gale J, Murray N. New Zealand ophthalmologists' opinions and behaviours on climate, carbon and sustainability. Clinical & experimental ophthalmology 2020. link
4 Waterman H, Grabham J. Ophthalmic theatre nursing. Part 1. Frameworks for practice. The British journal of theatre nursing : NATNews : the official journal of the National Association of Theatre Nurses 1995. link